MDLinx.com consistently provides the most current Dermatology medical news articles and clinical articles daily, from over 2,000 peer-reviewed journals. Topics covered range from: Cosmetic Dermatology, Clinical Pharmacology, Dermatologic Surgery and Dermatopathology, just to name few. The MDLinx medical editors meticulously categorize and summarize clinical articles daily within 24 hours of publication to keep you abreast of with the most relevant medical news.
On this page you may also find bonus content specifically chosen by our Physician Senior Editor D. Scott Cunningham, MD, PhD, along with clinical pearls from the Smartest Doc, our daily quiz competition and Dermatology Physician Review.
Sign up today to learn more about upcoming Dermatology conferences, Continuing Medical Education (CME) opportunities, receive daily newsletters and more.
Your Unread Messages in Dermatology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do.
Smartest Doc Challenge
MDLinx
Pediatric Dermatology Clinical Pearls
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Effective treatment of keloids
Jill Baker
MDLinx Career Center
New Jobs in Your Specialty
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs?
MDLinx Conference Center
MDLinx
June Conference Calendar
561 UK Consensus Statement on Safe Clinical Prescribing of Bexarotene for Patients with Cutaneous T-cell Lymphoma British Journal of Dermatology, September 11, 2012 Clinical Article
562 Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid British Journal of Dermatology, September 11, 2012 Clinical Article
563 Multiple metastatic epithelioid sarcoma stabilization under sunitinib malate treatment British Journal of Dermatology, September 11, 2012
564 Dose related efficacy of gabapentin in acute herpetic neuralgia among geriatric patients Full Text Indian Journal of Dermatology, September 10, 2012 Clinical Article
565 Photo-damage protective effect of two facial products, containing a unique complex of Dead Sea minerals and Himalayan actives Journal of Cosmetic Dermatology, September 10, 2012 Clinical Article
566 Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth Journal of Investigative Dermatology, September 7, 2012 Clinical Article
567 Botulinum Toxin A for the Treatment of Keloids Skin Pharmacology and Physiology, September 6, 2012 Clinical Article
568 Therapeutic effect of mizoribine on pemphigus vulgaris and pemphigus foliaceus Dermatologic Therapy, September 6, 2012 Clinical Article
569 Mizoribine treatment for antihistamine-resistant chronic autoimmune urticaria Dermatologic Therapy, September 6, 2012 Clinical Article
570 Efficacy and Patient-Reported Outcomes of a New Mometasone Cream Treating Atopic Eczema Skin Pharmacology and Physiology, September 6, 2012
571 Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies Full Text Indian Journal of Dermatology, Venereology and Leprology , September 5, 2012 Clinical Article
572 Reduction of facial wrinkles depth by sleeping on copper oxide-containing pillowcases: a double blind, placebo controlled, parallel, randomized clinical study Journal of Cosmetic Dermatology, September 5, 2012 Clinical Article
573 Effectiveness of isopropyl myristate/cyclomethicone D5 solution of removing cuticular hydrocarbons from human head lice (Pediculus humanus capitis) Full Text BMC Dermatology, September 5, 2012 Clinical Article
574 Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial The Lancet, August 30, 2012 Clinical Article
575 Dose escalation may be effective in psoriasis patients with treatment failure or suboptimal response, but switching to adalimumab is the most cost-effective measure in different scenarios British Journal of Dermatology, August 30, 2012 Clinical Article
576 Comparison of the Antipsoriatic Effect and Tolerability of Calcipotriol-Containing Products in the Treatment of Psoriasis Vulgaris Using a Modified Psoriasis Plaque Test Clinical Drug Investigation, August 29, 2012 Clinical Article
577 AbobotulinumtoxinA for Reduction of Glabellar Lines in Patients with Skin of Color: Post Hoc Analysis of Pooled Clinical Trial Data Dermatologic Surgery, August 29, 2012 Clinical Article
578 Evaluation of the Antiseptic Efficacy and Local Tolerability of a Polihexanide-Based Antiseptic on Resident Skin Flora Advances in Skin & Wound Care, August 29, 2012 Clinical Article
579 Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study British Journal of Dermatology, August 28, 2012 Clinical Article
580 Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056) British Journal of Dermatology, August 28, 2012 Clinical Article
As published in the Journal of European Academy of Dermatology & Venereology, measureable autoantibodies were associated with an increased extent of alopecia areata (AA). Ophiasic hair loss and nail dystrophy were associated with atopic AA, which in turn was associated with an increased risk of relapse.
Read the article summaryAs published in the Journal of Dermatology, injection of chondroitinase ABC into keloid grafted on to nude mice resulted in a significant reduction in keloid formation and elastic fiber formation.
Read the article summaryLL-37 corresponds to amino acids 134-170 in human cathelicidin, which is involved in innate immunity against cutaneous infections. Researchers at the Chinese University of Hong Kong conducted a study involving 144 children with eczema and 36 healthy children. The LL-37 levels were shown to be associated with the atopic dermatitis scores and the severity of eczema. The authors suggest that LL-37 is a biomarker of eczema severity in children and that innate immunity underlies the pathogenesis of eczema.
Read the article summary1 5% fluorouracil chemowraps in the management of widespread lower leg solar keratoses and squamous cell carcinoma Australasian Journal of Dermatology, May 10, 2013
2 Which Antipsoriatic Drug Has the Fastest Onset of Action?-Systematic Review on the Rapidity of the Onset of Action Journal of Investigative Dermatology, May 16, 2013 Evidence Based Medicine
3 The Chemopreventive Efficacies of Nonsteroidal Anti-inflammatory Drugs: the Relationship of Short-term Biomarkers to Long-term Skin Tumor Outcome Cancer Prevention Research, May 20, 2013
4 Isotretinoin 5 mg daily for low-grade adult acne vulgaris - a placebo-controlled, randomized double-blind study Journal of the European Academy of Dermatology and Venereology, April 29, 2013
5 Efficacy of rituximab in systemic manifestations of primary Sjogrens syndrome: results in 78 patients of the AutoImmune and Rituximab registry Annals of Rheumatic Diseases, May 21, 2013
6 Safety and efficacy of tazarotene foam for the treatment of acne vulgaris Clinical, Cosmetic and Investigational Dermatology, May 14, 2013 Free full text Review Article
7 Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication Journal of the European Academy of Dermatology and Venereology, May 9, 2013
8 Treatment of Mucous Membrane Pemphigoid With Mycophenolate Mofetil Cornea, May 17, 2013
9 Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses JAMA Dermatology, March 25, 2013
10 Pimecrolimus for psoriasis Expert Opinion on Pharmacotherapy, April 8, 2013
11 Salicylic Acid Peel Incorporating Triethyl Citrate and Ethyl Linoleate in the Treatment of Moderate Acne: A New Therapeutic Approach Dermatologic Surgery, May 1, 2013
12 Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis Journal of Dermatological Treatment , May 29, 2013 Review Article
13 An open-label study of anidulafungin for the treatment of candidaemia/invasive candidiasis in Latin America Mycoses, May 30, 2013
14 Three-Dimensional Remodeling of Young Womens Faces Using 20-mg/mL Smooth, Highly Cohesive, Viscous Hyaluronic Acid Fillers: A Retrospective Study of 320 Patients Dermatologic Surgery, May 7, 2013
15 Skin-protective effects of a zinc oxide-functionalized textile and its relevance for atopic dermatitis Clinical, Cosmetic and Investigational Dermatology, May 7, 2013 Free full text
16 Effect of the systemic use of methotrexate on the oxidative stress and paraoxonase enzyme in psoriasis patients Archives of Dermatological Research, May 22, 2013 Review Article
17 Minocycline-Induced Scleral and Dermal Pigmentation JAMA Ophthalmology, May 16, 2013
18 Anti-tnf agents and nail psoriasis: a single-center, retrospective, comparative study Journal of Dermatological Treatment , May 29, 2013 Review Article
19 What is the role of antimicrobial peptides (AMP) in acne vulgaris Experimental Dermatology, May 1, 2013
20 Patient reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: Findings through 2 years of the GO-REVEAL trial Arthritis Care & Research , May 13, 2013
Indexed Journals in Dermatology: American Journal of Clinical Dermatology, Contact Dermatitis, Dermatologic Surgery more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close